Renan Goude

Renan Goude

Auto-generated profile, based on publicly available information

Renan Goude

Univ. Rennes, CNRS, Institut de Génétique et Développement de Rennes (IGDR) UMR6290, Rennes, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2009 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
RGR. Goude
R. Goude
AAA. G. Amin
A. G. Amin
DCD. Chatterjee
D. Chatterjee
TPT. Parish
T. Parish
Ethambutol (EMB) is an antimycobacterial drug used extensively for the treatment of tuberculosis caused by Mycobacterium tuberculosis . EMB targets the biosynthesis of the cell wall, inhibiting the synthesis of both arabinogalactan and lipoarabinomannan (LAM), and is assumed to act via inhibition of three arabinosyltransferases: EmbA, EmbB, and EmbC. EmbA and EmbB are required for the synthesis of arabinogalactan, and at least one enzyme ( M. tuberculosis EmbA [EmbA Mt ]) is essential in M. tuberculosis . EmbC Mt is also essential for the viability of M. tuberculosis but is involved in the synthesis of LAM. We show that mutations in EmbC Mt that reduce its arabinosyltransferase activity result in increased sensitivity to EMB and the production of smaller LAM species in M. tuberculosis . Overexpression of EmbC Mt was not tolerated in M. tuberculosis , but overexpression of M ycobacterium smegmatis EmbC (EmbC Ms ) led to EMB resistance and the production of larger LAM species in M. tuberculosis . Treatment of wild-type M. tuberculosis strains with EMB led to inhibition of LAM synthesis, resulting in the production of smaller species of LAM. In contrast, no change in LAM production was seen in EMB-resistant strains. Overexpression of EmbB Ms in M. tuberculosis also resulted in EMB resistance, but at a lower level than that caused by EmbC Ms . Overexpression of EmbA Mt in M. tuberculosis had no effect on EMB resistance. Thus, there is a direct correlation between EmbC activity and EMB resistance, as well as between EmbC activity and the size of the LAM species produced, confirming that EmbC is one of the cellular targets of EMB action.

1 November 2004 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
PDF file
RGRenan Goude
Renan Goude
SRStéphanie Renaud
Stéphanie Renaud
SBSylvie Bonnassie
Sylvie Bonnassie
TBThéophile Bernard
Théophile Bernard
CBCarlos Blanco
Carlos Blanco
Erwinia chrysanthemi is a phytopathogenic soil enterobacterium closely related to Escherichia coli . Both species respond to hyperosmotic pressure and to external added osmoprotectants in a similar way. Unexpectedly, the pools of endogenous osmolytes show different compositions. Instead of the commonly accumulated glutamate and trehalose, E. chrysanthemi strain 3937 promotes the accumulation of glutamine and α-glucosylglycerate, which is a new osmolyte for enterobacteria, together with glutamine. The amounts of the three osmolytes increased with medium osmolarity and were reduced when betaine was provided in the growth medium. Both glutamine and glutamate showed a high rate of turnover, whereas glucosylglycerate stayed stable. In addition, the balance between the osmolytes depended on the osmolality of the medium. Glucosylglycerate and glutamate were the major intracellular compounds in low salt concentrations, whereas glutamine predominated at higher concentrations. Interestingly, the ammonium content of the medium also influenced the pool of osmolytes. During bacterial growth with 1 mM ammonium in stressing conditions, more glucosylglycerate accumulated by far than the other organic solutes. Glucosylglycerate synthesis has been described in some halophilic archaea and bacteria but not as a dominant osmolyte, and its role as an osmolyte in Erwinia chrysanthemi 3937 shows that nonhalophilic bacteria can also use ionic osmolytes.

14 February 2015
Verified
Book Chapter
Closed access
PDF file
RGRenan Goude
Renan Goude
DRDavid M. Roberts
David M. Roberts
TPTanya Parish
Tanya Parish

1 January 2008 in Microbiology
Verified
Journal Article
Open access
AAAnita G. Amin
Anita G. Amin
RGRenan Goude
Renan Goude
LSLibin Shi
Libin Shi
JZJian Zhang
Jian Zhang
DCDelphi Chatterjee
Delphi Chatterjee
TPTanya Parish
Tanya Parish
The Emb proteins (EmbA, EmbB, EmbC) are mycobacterial arabinosyltransferases involved in the biogenesis of the mycobacterial cell wall. EmbA and EmbB are predicted to work in unison as a heterodimer. EmbA and EmbB are involved in the formation of the crucial terminal hexaarabinoside motif [Araβ(1→2)Araα(1→5)] [Araβ(1→2)Araα(1→3)]Araα(1→5)Araα1→(Ara6) in the cell wall polysaccharide arabinogalactan. Studies conducted in Mycobacterium smegmatis revealed that mutants with disruptions in embA or embB are viable, although the growth rate was affected. In contrast, we demonstrate here that embA is an essential gene in Mycobacterium tuberculosis, since a deletion of the chromosomal gene could only be achieved when a second functional copy was provided on an integrated vector. Complementation of an embA mutant of M. smegmatis by M. tuberculosis embA confirmed that it encodes a functional arabinosyltransferase. We identified a promoter for M. tuberculosis embA located immediately upstream of the gene, indicating that it is expressed independently from the upstream gene, embC. Promoter activity from P embA (Mtb) was sevenfold lower when assayed in M. smegmatis compared to M. tuberculosis, indicating that the latter is not a good host for genetic analysis of M. tuberculosis embA expression. P embA (Mtb) activity remained constant throughout growth phases and after stress treatment, although it was reduced during hypoxia-induced non-replicating persistence. Ethambutol exposure had no effect on P embA (Mtb) activity. These data demonstrate that M. tuberculosis embA encodes a functional arabinosyltransferase which is constitutively expressed and plays a critical role in M. tuberculosis.

15 June 2008 in Journal of Bacteriology
Verified
Journal Article
Closed access
RGRenan Goude
Renan Goude
AAAnita G. Amin
Anita G. Amin
DCDelphi Chatterjee
Delphi Chatterjee
TPTanya Parish
Tanya Parish
Arabinan polymers are major components of the cell wall inMycobacterium tuberculosisand are involved in maintaining its structure, as well as playing a role in host-pathogen interactions. In particular, lipoarabinomannan (LAM) has multiple immunomodulatory effects. In the nonpathogenic speciesMycobacterium smegmatis, EmbC has been identified as a key arabinosyltransferase involved in the incorporation of arabinose into LAM, and anembCmutant is viable but lacks LAM. In contrast, we demonstrate here that inM. tuberculosis,embCis an essential gene under normal growth conditions, suggesting a more crucial role for LAM in the pathogenic mycobacteria.M. tuberculosisEmbC has an activity similar to that ofM. smegmatisEmbC, since we were able to complement anembCmutant ofM. smegmatiswithembCMtb, confirming that it encodes a functional arabinosyltransferase. In addition, we observed that the size of LAM produced inM. smegmatiswas dependent on the level of expression ofembCMtb. Northern analysis revealed thatembCis expressed as part of a polycistronic message encompassingembCand three upstream genes. The promoter region for this transcript was identified and found to be up-regulated in stationary phase but down-regulated during hypoxia-induced nonreplicating persistence. In conclusion, we have identified one of the key genes involved in LAM biosynthesis inM. tuberculosisand confirmed its essential role in this species.

1 January 2009
Verified
Book Chapter
Closed access
PDF file
RGRenan Goude
Renan Goude
TPTanya Parish
Tanya Parish